Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

This episode is sponsored by Endel, an app that creates personalized soundscapes to help you focus, relax and sleep. Could ...

Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood ...

Patients who listen to music during surgery need less propofol for staying unconscious and fewer additional doses of fentanyl ...

In their new study, the LJI scientists are the first to show that GPR25 is induced by a signaling molecule called TGF-β.

Memory Lift's inclusion of Vitamin C ensures robust antioxidant defense while simultaneously supporting the neurochemical ...

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight.